C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/25/2004	WO2004073646A3 Treatment of pain through expression of opioid receptors
11/25/2004	WO2004072095A3 Cyclized peptides as exotoxin antagonists
11/25/2004	WO2004067032A3 Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes
11/25/2004	WO2004065603A3 Methods for increasing neisseria protein expression
11/25/2004	WO2004063223A3 Notch-like polypeptides
11/25/2004	WO2004050705A3 Complexes of receptors
11/25/2004	WO2004048518A3 Organelle-associated proteins
11/25/2004	WO2004037294A3 New settings for recombinant adenoviral-based vaccines
11/25/2004	WO2004034977A3 Orally administered peptides synergize statin activity
11/25/2004	WO2004030619A8 Protein s protects the nervous system from injury
11/25/2004	WO2004029084A3 Lipase inhibitors and uses thereof
11/25/2004	WO2004024888A3 WNHs AS MODIFIERS OF p53, p21, AND BRANCHING MORPHOGENESIS PATHWAYS AND METHODS OF USE
11/25/2004	WO2004018624A3 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes
11/25/2004	WO2004009786A3 Modulators of leukocyte activation, bic compositions and methods of use
11/25/2004	WO2003103589A3 Use of il-21 in cancer and other therapeutic applications
11/25/2004	WO2003082924A8 Immunotherapeutic and immunoprophylactic reagents
11/25/2004	WO2003082906A3 Neurotrophic and neuroprotective peptides
11/25/2004	WO2003078648A3 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
11/25/2004	WO2003078578A3 Modulation of the immune response through the manipulation of arginine levels
11/25/2004	WO2003073984A3 Tat as an immunogen
11/25/2004	WO2003070906A3 Cellular genes regulated by hiv-1 infection and methods of use thereof
11/25/2004	WO2003070892A3 Inhibitors of rgs proteins
11/25/2004	WO2003050260A3 Streptavidin expressed gene fusions and methods of use thereof
11/25/2004	WO2003050239A3 Crystals and structures of members of the e. coli coma and yddb protein families (coma)
11/25/2004	WO2003025148A3 Novel nucleic acids and polypeptides
11/25/2004	WO2003004676A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/25/2004	WO2002078524A3 Translational profiling
11/25/2004	WO2002020556A3 Haplotypes of the gpr68 gene
11/25/2004	WO2001055338A3 7tm receptor axor51
11/25/2004	US20040237141 Plant gene regeneration; hybrids; reducing glucosinolates
11/25/2004	US20040237137 Solanum bulbocastanum late blight resistance gene and use thereof
11/25/2004	US20040237136 Transforming, propagating and generating cucumber green mottle mosaic virus (CGMMV) resistant cucurbitaceae; disease resistant plants
11/25/2004	US20040237135 ZmAXIG1 polynucleotides and methods of use
11/25/2004	US20040237132 Plant promoters
11/25/2004	US20040237129 Transgenic rodent model for use in identifying modulators for treatment of cell proliferative disorders; antitumor agents; immunotherapy
11/25/2004	US20040237128 Transgenic non-human animal having a disruption of at least one allele to the ceacam 1 gene and method of making same
11/25/2004	US20040237127 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
11/25/2004	US20040236093 Using chimeric dendritic cells comprising viral epitopes to generate vaccines to prevent and treat viral diseases
11/25/2004	US20040236092 Peptidologlycan recognition protein encoding nucleic acids and methods of use thereof
11/25/2004	US20040236091 Nucleotide sequences coding major histocompatibility complex proteins for use in diagnosis, prevention and treatment of cell proliferative disorders
11/25/2004	US20040236090 Methods and materials relating to fibulin like polypeptides and polynucleotides
11/25/2004	US20040236088 Nucleotide sequences coding transmembrane protein for use in generating monoclonal antibodies for treatment and prevention of diabetes, allergies, autoimmune, inflammatory, cell proliferative and infectious diseases
11/25/2004	US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004	US20040236082 Modified pyrogenic toxin for use in developing vaccine for prevention and treatment of toxic shock syndrome and food poisoning
11/25/2004	US20040236075 Novel glass II cytokine receptors, and uses thereof
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004	US20040235776 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
11/25/2004	US20040235775 Inhibition of hepatitis B virus (HBV) replication by RNA interference
11/25/2004	US20040235772 DNA expression construct for the treatment of infections with leishmaniasis
11/25/2004	US20040235771 Means for eliciting an immune response and a method therefor
11/25/2004	US20040235768 Human platelet F11 receptor
11/25/2004	US20040235766 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/25/2004	US20040235765 Administering as antitumor or anticarcinogenic agent; interference RNA
11/25/2004	US20040235746 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
11/25/2004	US20040235745 Basic polypeptide against Grampositive and Gramnegative bacteria; noncytoxic
11/25/2004	US20040235743 Soluble zalpha11 cytokine receptors
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235738 Novel antimicrobial peptide isolated from penaeus monodon
11/25/2004	US20040235736 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/25/2004	US20040235735 Gene expression of cells; genetic engineering using tripeptides; antiinflammatory agents; apoptosis;medical diagnosis
11/25/2004	US20040235732 Method for modulating angiogenesis using prokineticin receptor antagonists
11/25/2004	US20040235730 Non-naturally occurring lipoprotein particle
11/25/2004	US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
11/25/2004	US20040235721 Relates to polynucleotides coding for PPVO viral genome, to fragments of polynucleotides coding for PPVO genome and to polynucleotides coding for individual open reading frames of PPVO viral genome; for treatment of viral, non-viral infections, proliferative, inflammatory, autoimmune diseases
11/25/2004	US20040235720 May also be used in combination with an interferon for treatment and/or prevention of diseases such as traumatic nerve injury, stroke, demyelinating diseases of the CNS or PNS, neuropathies and neurodegenerative diseases
11/25/2004	US20040235717 Suppression of androgen receptor transactivation through new pathways to ar and ar coactivators and repressors
11/25/2004	US20040235715 Obtaining mammalian cells which contain a nucleic acid coding sequence for the bikunin, culturing cells in culture system under conditions sufficient to allow cells to express bikunin, the mammalian cells being capable of glycosylating the bikunin, recovering glycosylated bikunin
11/25/2004	US20040235714 Nucleic acid molecule comprising sequence which encodes a neurotrophic factor receptor protein capable of complexing with glial cell line-derived neurotrophic factor or neurturin neurotrophic factor thereby mediating cell response to said neurotrophic factor; treatment of Parkinson's, Alzheimer's disease
11/25/2004	US20040235713 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
11/25/2004	US20040235709 Gssp3 polynucleotides and polypeptides and uses thereof
11/25/2004	US20040235174 Adenoviral expression vector comprising red fluorescent protein reporter for use as heterologous gene transfer tool
11/25/2004	US20040235173 Production of host cells containing multiple integrating vectors by serial transduction
11/25/2004	US20040235140 Transgenic microorganism for use as bioreactor for expression of heterologous genes and proteins; antigen production and vaccine development
11/25/2004	US20040235137 Novel lanthionine antibiotic compositions and methods
11/25/2004	US20040235136 Novel protein molecule useful for inhibition of anthrax toxin
11/25/2004	US20040235135 Preparing viral nucleotide sequences where immune response-inducing antigen sequences are repositioned in the position closest to the 3' end and viral replication limiting factor gene is repositioned away from 3' promoter; for use in generating vaccine to treat and prevent viral infectious diseases
11/25/2004	US20040235134 Newcastle disease virus infectious clones, vaccines and new diagnostic assays
11/25/2004	US20040235133 Large scale production of packaged alphavirus replicons
11/25/2004	US20040235132 Helper cell comprising coronavirus permissive cell, replicon RNA and helper RNA: for use in producing assembled coronavirus particles which comprise heterologous RNA sequences, is able to infect cells and is unable to complete viral replication in absence of helper RNA; heterologous gene expression
11/25/2004	US20040235131 Green fluorescent proteins and blue fluorescent proteins
11/25/2004	US20040235129 KDEL receptor inhibitors
11/25/2004	US20040235118 Portions of soluble recombinant botulinum toxins
11/25/2004	US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004	US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004	US20040235115 Comprises serine protease for use in treating and preventing heart attack, stroke, gangrene, deep venous thrombosis and peripheral arterial occlusion; fibrinolytic therapy
11/25/2004	US20040235113 18 human secreted proteins
11/25/2004	US20040235111 Tumor supressor gene p33ING2
11/25/2004	US20040235110 Immunoglobulin for use in identifying polypeptides which inhibit cell proliferation; immunoassay; immunodiagnostics
11/25/2004	US20040235109 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/25/2004	US20040235104 Nucleotide sequences coding similar expression of fibroblast growth factors genes (SEF) for use as tools in identifying modulators of cardiovascular, urogenital and cell proliferative disorders
11/25/2004	US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders
11/25/2004	US20040235100 Renilla reniformis green fluorescent protein and mutants thereof
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235096 Method for regulating dopamine producing cells
11/25/2004	US20040235095 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
11/25/2004	US20040235093 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof
11/25/2004	US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004	US20040235091 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
11/25/2004	US20040235090 Fermenting somatotropin from transgenic escherichia and using dipeptidyl aminopeptidase to modify terminal; bioreactors and heterologous gene expression

1 ... 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 ... 2916